Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:INSP NASDAQ:LIVN NASDAQ:TNDM NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINSPInspire Medical Systems$93.86+2.6%$113.86$73.92▼$225.00$2.77B1.221.73 million shs656,389 shsLIVNLivaNova$56.37+1.7%$47.53$32.48▼$57.35$3.08B0.92790,593 shs472,571 shsTNDMTandem Diabetes Care$12.51+6.1%$14.77$9.98▼$47.60$845.29M1.462.86 million shs1.44 million shsWRBYWarby Parker$26.16-0.3%$24.01$12.69▼$29.73$2.76B2.091.85 million shs1.01 million shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINSPInspire Medical Systems+2.72%-2.02%-28.60%-32.00%-48.77%LIVNLivaNova+1.66%+0.84%+28.08%+30.52%+16.61%TNDMTandem Diabetes Care+6.11%+4.86%-24.96%-36.91%-71.81%WRBYWarby Parker-0.38%-3.16%+10.68%+23.42%+70.45%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINSPInspire Medical Systems4.9821 of 5 stars4.34.00.04.84.01.73.1LIVNLivaNova1.7269 of 5 stars1.53.00.00.04.01.71.3TNDMTandem Diabetes Care4.5092 of 5 stars4.13.00.04.92.61.70.6WRBYWarby Parker2.0947 of 5 stars2.32.00.00.03.53.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINSPInspire Medical Systems 2.54Moderate Buy$165.6276.44% UpsideLIVNLivaNova 3.00Buy$59.715.93% UpsideTNDMTandem Diabetes Care 2.27Hold$22.4779.59% UpsideWRBYWarby Parker 2.58Moderate Buy$24.06-8.03% DownsideCurrent Analyst Ratings BreakdownLatest TNDM, LIVN, INSP, and WRBY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/21/2025LIVNLivaNovaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$55.00 ➝ $58.008/21/2025TNDMTandem Diabetes CareCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$10.35 ➝ $11.008/15/2025INSPInspire Medical SystemsLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$116.00 ➝ $97.008/11/2025TNDMTandem Diabetes CareLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$75.00 ➝ $12.008/8/2025WRBYWarby ParkerCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy8/8/2025WRBYWarby ParkerUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$20.00 ➝ $23.008/8/2025TNDMTandem Diabetes CareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$53.00 ➝ $51.008/8/2025WRBYWarby ParkerStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$21.00 ➝ $22.008/7/2025WRBYWarby ParkerEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingPositive ➝ Positive8/7/2025TNDMTandem Diabetes CareCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$59.00 ➝ $24.008/7/2025TNDMTandem Diabetes CarePiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$30.00 ➝ $14.00(Data available from 8/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINSPInspire Medical Systems$802.80M3.46$1.71 per share54.83$22.92 per share4.10LIVNLivaNova$1.25B2.46$4.24 per share13.29$20.56 per share2.74TNDMTandem Diabetes Care$940.20M0.90N/AN/A$1.97 per share6.35WRBYWarby Parker$771.32M3.57$0.34 per share77.17$3.44 per share7.61Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINSPInspire Medical Systems$53.51M$1.7340.7329.152.926.17%10.38%8.93%11/3/2025 (Estimated)LIVNLivaNova$63.23M-$3.89N/A17.95N/A-16.13%14.57%6.91%10/29/2025 (Estimated)TNDMTandem Diabetes Care-$96.03M-$3.09N/AN/AN/A-20.51%-65.40%-13.87%11/5/2025 (Estimated)WRBYWarby Parker-$20.39M-$0.07N/A261.64N/A-1.12%-0.79%-0.41%11/6/2025 (Estimated)Latest TNDM, LIVN, INSP, and WRBY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025LIVNLivaNova$0.84$1.05+$0.21$0.50$332.20 million$352.50 million8/6/2025Q2 2025TNDMTandem Diabetes Care-$0.40-$0.48-$0.08-$0.78$238.39 million$240.68 million8/4/2025Q2 2025INSPInspire Medical Systems$0.22$0.45+$0.23-$0.12$214.50 million$217.09 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINSPInspire Medical SystemsN/AN/AN/AN/AN/ALIVNLivaNovaN/AN/AN/AN/AN/ATNDMTandem Diabetes CareN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINSPInspire Medical SystemsN/A6.144.84LIVNLivaNova0.311.291.09TNDMTandem Diabetes Care2.322.441.88WRBYWarby ParkerN/A2.552.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINSPInspire Medical Systems94.91%LIVNLivaNova97.64%TNDMTandem Diabetes CareN/AWRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipINSPInspire Medical Systems4.10%LIVNLivaNova0.29%TNDMTandem Diabetes Care1.90%WRBYWarby Parker18.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINSPInspire Medical Systems1,24629.57 million28.36 millionOptionableLIVNLivaNova2,90054.60 million54.44 millionOptionableTNDMTandem Diabetes Care2,65067.57 million66.29 millionOptionableWRBYWarby Parker3,780105.19 million86.00 millionOptionableTNDM, LIVN, INSP, and WRBY HeadlinesRecent News About These Companies87,616 Shares in Warby Parker Inc. $WRBY Bought by Mission Creek Capital Partners Inc.August 30 at 7:15 AM | marketbeat.comWarby Parker Announces Participation in the Goldman Sachs 32nd Annual Global Retailing ConferenceAugust 28 at 4:05 PM | businesswire.comHershey Trust Co. Purchases Shares of 63,994 Warby Parker Inc. $WRBYAugust 28 at 9:31 AM | marketbeat.com97,436 Shares in Warby Parker Inc. $WRBY Bought by Capital Fund Management S.A.August 28 at 4:51 AM | marketbeat.comRussell Investments Group Ltd. Has $2.10 Million Stock Holdings in Warby Parker Inc. $WRBYAugust 28 at 3:37 AM | marketbeat.comBrokerages Set Warby Parker Inc. (NYSE:WRBY) Target Price at $24.06August 28 at 2:29 AM | americanbankingnews.comWarby Parker Teams Up with Arch Manning for Three-Year PartnershipAugust 27 at 1:47 PM | finance.yahoo.comWarby Parker Inc. $WRBY Stake Boosted by Jump Financial LLCAugust 27 at 7:01 AM | marketbeat.comAlgert Global LLC Cuts Stake in Warby Parker Inc. $WRBYAugust 27 at 4:02 AM | marketbeat.comWarby Parker Inc. (NYSE:WRBY) Receives Average Recommendation of "Moderate Buy" from AnalystsAugust 26, 2025 | marketbeat.comQuantbot Technologies LP Acquires 43,863 Shares of Warby Parker Inc. $WRBYAugust 25, 2025 | marketbeat.comWarby Parker (NYSE:WRBY) Raised to "Buy" at Wall Street ZenAugust 25, 2025 | marketbeat.com16,600 Shares in Warby Parker Inc. $WRBY Bought by Versor Investments LPAugust 24, 2025 | marketbeat.comWarby Parker (NYSE:WRBY) Raised to Buy at Wall Street ZenAugust 24, 2025 | americanbankingnews.comEntryPoint Capital LLC Acquires New Shares in Warby Parker Inc. $WRBYAugust 23, 2025 | marketbeat.comAmerican Century Companies Inc. Has $44.79 Million Stock Position in Warby Parker Inc. $WRBYAugust 23, 2025 | marketbeat.comVanguard Group Inc. Has $176.82 Million Holdings in Warby Parker Inc. $WRBYAugust 22, 2025 | marketbeat.comNorthwest & Ethical Investments L.P. Cuts Stake in Warby Parker Inc. $WRBYAugust 21, 2025 | marketbeat.comCetera Investment Advisers Makes New $319,000 Investment in Warby Parker Inc. $WRBYAugust 21, 2025 | marketbeat.comFox Run Management L.L.C. Makes New $552,000 Investment in Warby Parker Inc. $WRBYAugust 20, 2025 | marketbeat.comLord Abbett & CO. LLC Has $6.58 Million Position in Warby Parker Inc. (NYSE:WRBY)August 19, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTNDM, LIVN, INSP, and WRBY Company DescriptionsInspire Medical Systems NYSE:INSP$93.86 +2.40 (+2.63%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$92.75 -1.11 (-1.19%) As of 08/29/2025 05:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.LivaNova NASDAQ:LIVN$56.37 +0.92 (+1.66%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$56.38 +0.01 (+0.01%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.Tandem Diabetes Care NASDAQ:TNDM$12.51 +0.72 (+6.11%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$12.48 -0.03 (-0.20%) As of 08/29/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.Warby Parker NYSE:WRBY$26.16 -0.08 (-0.29%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$26.21 +0.05 (+0.18%) As of 08/29/2025 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
